---
title: "Oncogenic mTOR mutations are detrimental in nutrient-poor conditions"
description: |
  In: Cancer Research 2022
preview: preview.jpg
date: 01-09-2022
categories:
  - driver mutations
  - oncogenesis
  - peer reviewed
output: 
  distill::distill_article:
    toc: false
draft: false
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = FALSE)
```

```{css echo=F}
a.button{
  display:inline;
  padding:0.35em 1.2em;
  border:0.1em solid #0F2E3D;
  margin: 1.2em 0em 0em 0.3em;
  border-radius: 0.25rem;
  box-sizing: border-box;
  text-decoration:none;
  font-family: 'Open Sans', sans-serif;
  font-weight:400;
  font-size: 1.3em;
  color: #0F2E3D;
  text-align:center;
  transition: all 0.2s;
}

a.button:hover{
 color:#FFFFFF;
 background-color:#0F2E3D;
}
```

<center>
  <a href="https://doi.org/TODO" class="button">paper</a>
  <a href="https://github.com/morrislab/mtor-rcc" class="button">code</a>
</center>

<br>


# Key Ideas

* Many cancers lack activating mTOR mutations, but this is not the case in Renal Clear Cell Carcinoma (RCCC)
* mTOR is involved in several important pathways: including growth, and nutrient sensing
* In nutrient-rich conditions (such as in hypervascular kidney tissue), disregulated mTOR may be less detrimental for survival than in nutrient-poor conditions, accounting for the enrichment mTOR mutations in RCCC.


# Citation

TODO
